Table of Contents

1 Study Coverage

• 1.1 Molecular Microbiology Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Molecular Microbiology Market Size Growth Rate by Product
  • 1.4.2 Quantitative PCR Detection Diagnostic Kits
  • 1.4.3 Pathogenic Microorganisms Diagnostic Kits
• 1.5 Market by End User
  • 1.5.1 Global Molecular Microbiology Market Size Growth Rate by End User
  • 1.5.2 Human
  • 1.5.3 Veterinary
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Molecular Microbiology Market Size
  • 2.1.1 Global Molecular Microbiology Revenue 2014-2025
  • 2.1.2 Global Molecular Microbiology Sales 2014-2025
• 2.2 Molecular Microbiology Growth Rate by Regions
  • 2.2.1 Global Molecular Microbiology Sales by Regions
  • 2.2.2 Global Molecular Microbiology Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Molecular Microbiology Sales by Manufacturers
  • 3.1.1 Molecular Microbiology Sales by Manufacturers
  • 3.1.2 Molecular Microbiology Sales Market Share by Manufacturers
  • 3.1.3 Global Molecular Microbiology Market Concentration Ratio (CR5 and HHI)
• 3.2 Molecular Microbiology Revenue by Manufacturers
  • 3.2.1 Molecular Microbiology Revenue by Manufacturers (2014-2019)
  • 3.2.2 Molecular Microbiology Revenue Share by Manufacturers (2014-2019)
• 3.3 Molecular Microbiology Price by Manufacturers
• 3.4 Molecular Microbiology Manufacturing Base Distribution, Product Types
  • 3.4.1 Molecular Microbiology Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Molecular Microbiology Product Type
  • 3.4.3 Date of International Manufacturers Enter into Molecular Microbiology Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Molecular Microbiology Sales by Product
• 4.2 Global Molecular Microbiology Revenue by Product
• 4.3 Molecular Microbiology Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Molecular Microbiology Breakdown Data by End User

6 North America

• 6.1 North America Molecular Microbiology by Countries
  • 6.1.1 North America Molecular Microbiology Sales by Countries
  • 6.1.2 North America Molecular Microbiology Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Molecular Microbiology by Product
• 6.3 North America Molecular Microbiology by End User

7 Europe

• 7.1 Europe Molecular Microbiology by Countries
  • 7.1.1 Europe Molecular Microbiology Sales by Countries
  • 7.1.2 Europe Molecular Microbiology Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Molecular Microbiology by Product
• 7.3 Europe Molecular Microbiology by End User

8 Asia Pacific

• 8.1 Asia Pacific Molecular Microbiology by Countries
  • 8.1.1 Asia Pacific Molecular Microbiology Sales by Countries
  • 8.1.2 Asia Pacific Molecular Microbiology Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Molecular Microbiology by Product
• 8.3 Asia Pacific Molecular Microbiology by End User

9 Central & South America

• 9.1 Central & South America Molecular Microbiology by Countries
  • 9.1.1 Central & South America Molecular Microbiology Sales by Countries
  • 9.1.2 Central & South America Molecular Microbiology Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Molecular Microbiology by Product
• 9.3 Central & South America Molecular Microbiology by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Molecular Microbiology by Countries
  • 10.1.1 Middle East and Africa Molecular Microbiology Sales by Countries
  • 10.1.2 Middle East and Africa Molecular Microbiology Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Molecular Microbiology by Product
• 10.3 Middle East and Africa Molecular Microbiology by End User

11 Company Profiles

• 11.1 Roche
  • 11.1.1 Roche Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Roche Molecular Microbiology Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Roche Molecular Microbiology Products Offered
  • 11.1.5 Roche Recent Development
• 11.2 Qiagen
  • 11.2.1 Qiagen Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Qiagen Molecular Microbiology Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Qiagen Molecular Microbiology Products Offered
  • 11.2.5 Qiagen Recent Development
• 11.3 Illumina
  • 11.3.1 Illumina Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Illumina Molecular Microbiology Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Illumina Molecular Microbiology Products Offered
  • 11.3.5 Illumina Recent Development
• 11.4 Abbott
  • 11.4.1 Abbott Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Abbott Molecular Microbiology Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Abbott Molecular Microbiology Products Offered
  • 11.4.5 Abbott Recent Development
• 11.5 Hologic
  • 11.5.1 Hologic Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Hologic Molecular Microbiology Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Hologic Molecular Microbiology Products Offered
  • 11.5.5 Hologic Recent Development
• 11.6 BioMerieux
  • 11.6.1 BioMerieux Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 BioMerieux Molecular Microbiology Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 BioMerieux Molecular Microbiology Products Offered
  • 11.6.5 BioMerieux Recent Development
• 11.7 Danaher (Cepheid)
  • 11.7.1 Danaher (Cepheid) Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Danaher (Cepheid) Molecular Microbiology Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Danaher (Cepheid) Molecular Microbiology Products Offered
  • 11.7.5 Danaher (Cepheid) Recent Development
• 11.8 Myriad Genetics
  • 11.8.1 Myriad Genetics Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Myriad Genetics Molecular Microbiology Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Myriad Genetics Molecular Microbiology Products Offered
  • 11.8.5 Myriad Genetics Recent Development
• 11.9 DAAN Gene
  • 11.9.1 DAAN Gene Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 DAAN Gene Molecular Microbiology Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 DAAN Gene Molecular Microbiology Products Offered
  • 11.9.5 DAAN Gene Recent Development
• 11.10 Agilent
  • 11.10.1 Agilent Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Agilent Molecular Microbiology Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Agilent Molecular Microbiology Products Offered
  • 11.10.5 Agilent Recent Development
• 11.11 Genomic Health
• 11.12 BD
• 11.13 Foundation Medicine

12 Future Forecast

• 12.1 Molecular Microbiology Market Forecast by Regions
  • 12.1.1 Global Molecular Microbiology Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Molecular Microbiology Revenue Forecast by Regions 2019-2025
• 12.2 Molecular Microbiology Market Forecast by Product
  • 12.2.1 Global Molecular Microbiology Sales Forecast by Product 2019-2025
  • 12.2.2 Global Molecular Microbiology Revenue Forecast by Product 2019-2025
• 12.3 Molecular Microbiology Market Forecast by End User
• 12.4 North America Molecular Microbiology Forecast
• 12.5 Europe Molecular Microbiology Forecast
• 12.6 Asia Pacific Molecular Microbiology Forecast
• 12.7 Central & South America Molecular Microbiology Forecast
• 12.8 Middle East and Africa Molecular Microbiology Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Molecular Microbiology Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Molecular diagnostics is a collection of techniques used to analyze biological markers in the genome and proteome—the individual's genetic code and how their cells express their genes as proteins—by applying molecular biology to medical testing.

Mainly because of their relative simplicity, ease of manipulation and growth in vitro, and importance in medicine, bacteria were instrumental in the development of molecular biology.
Molecular diagnostics are highly effective in diagnosing infectious diseases and performing preventive cancer screening thus helping healthcare professionals to prescribe accurate therapeutic interventions in the early stages of diseases. Increasing prevalence of hospital acquired infections and other communicable infections are anticipated to drive the sector expansion over the forecast period.
The classification of molecular microbiology includes quantitative PCR detection diagnostic kits, pathogenic microorganisms’ diagnostic kits and other. The proportion of pathogenic microorganisms’ diagnostic kits in 2016 is about 45.8%. PCR was the largest segment in terms of revenue generation, Moreover, the growing availability of diseases-specific; real time PCR kits are further estimated to boost the growth.
Molecular Microbiology is application for human and veterinary. The most of Molecular Microbiology is used for human, and the market share in 2016 is about 92.5%.
The global Molecular Microbiology market is valued at 4630 million US$ in 2018 and will reach 8680 million US$ by the end of 2025, growing at a CAGR of 8.2% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Molecular Microbiology market based on company, product type, end user and key regions.

This report studies the global market size of Molecular Microbiology in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Molecular Microbiology in these regions.
This research report categorizes the global Molecular Microbiology market by top players/brands, region, type and end user. This report also studies the global Molecular Microbiology market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Roche
Qiagen
Illumina
Abbott
Hologic
BioMerieux
Danaher (Cepheid)
Myriad Genetics
DAAN Gene
Agilent
Genomic Health
BD
Foundation Medicine

Market size by Product
Quantitative PCR Detection Diagnostic Kits
Pathogenic Microorganisms Diagnostic Kits
Market size by End User
Human
Veterinary

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Molecular Microbiology market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Molecular Microbiology market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Molecular Microbiology companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Molecular Microbiology submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Molecular Microbiology are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (M Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Molecular Microbiology market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.